Search hospitals > New York > New York
Hospital for Special Surgery
Claim this profileNew York, New York 10021
Global Leader in Osteoarthritis
Global Leader in Multiple Sclerosis
Conducts research for Arthritis
Conducts research for Systemic Scleroderma
Conducts research for Scleroderma
383 reported clinical trials
57 medical researchers
Summary
Hospital for Special Surgery is a medical facility located in New York, New York. This center is recognized for care of Osteoarthritis, Multiple Sclerosis, Arthritis, Systemic Scleroderma, Scleroderma and other specialties. Hospital for Special Surgery is involved with conducting 383 clinical trials across 382 conditions. There are 57 research doctors associated with this hospital, such as Dale J Lange, MD, Karen Onel, MD, Robert Spiera, MD, and Jose Rodriguez, MD.Top PIs
Dale J Lange, MDHospital for Special Surgery4 years of reported clinical research
Studies Motor Neuron Disease
Studies Amyotrophic Lateral Sclerosis
5 reported clinical trials
10 drugs studied
Karen Onel, MDHospital for Special Surgery1 year of reported clinical research
Studies Arthritis
Studies Rheumatoid Arthritis
5 reported clinical trials
9 drugs studied
Robert Spiera, MDHospital for Special Surgery5 years of reported clinical research
Studies Scleroderma
Studies Systemic Scleroderma
5 reported clinical trials
5 drugs studied
Jose Rodriguez, MDSouthwest General Healthcare Center6 years of reported clinical research
Studies Cushing's Syndrome
Studies Cushing Syndrome
6 reported clinical trials
7 drugs studied
Clinical Trials running at Hospital for Special Surgery
Osteoarthritis
Scleroderma
Complex Regional Pain Syndrome
Multiple Sclerosis
Antiphospholipid Syndrome
Systemic Scleroderma
Systemic Sclerosis
Opioid Use Disorder
Anterior Cruciate Ligament Injury
Systemic Lupus Erythematosus
PRP Injections
for Shoulder Osteoarthritis
The glenohumeral joint is the third most common large joint to be affected by OA. Conservative treatments include physical activity, corticosteroid injections, and medications. PRP is an emerging treatment that has shown efficacy in different musculoskeletal conditions. The use of PRP for glenohumeral OA has been described sparingly in the literature but has shown efficacy in a couple studies and case reports. However, all of the previous studies investigating PRP for glenohumeral OA have focused on low-dose PRP preparations (\~3X), and none have compared PRP treatment to saline treatment. This study aims to compare outcomes following single injections of low-dose PRP, high-dose PRP, or saline in patients with glenohumeral osteoarthritis.
Recruiting2 awards Phase 4
PRP Injections
for ACL Injury
The purpose of our study is to examine the effect of platelet-rich-plasma (PRP) injection on the short-term resolution of post-injury inflammation (biomarkers) and improvement in joint function in patients with acute ACL injury. This RCT has been powered based on the questionnaire KOOS Jr. but it is considered a 'pilot study' in terms of the lab analysis proposed.
Recruiting2 awards Phase 43 criteria
Cannabidiol
for Knee Surgery Pain
In light of the opioid epidemic and evidence suggesting that cannabis may be opioid-sparing, we are in a unique position to conduct a novel, high-impact study that would set the stage for future RCTs examining the effects of a nonintoxicating and nonaddictive cannabinoid in an orthopedic patient population. Epidiolex®, an oral cannabidiol (CBD) solution, is the first ever cannabis-derived medication to be approved by the Food \& Drug Administration. Our aim is to conduct a pilot study using a placebo oral solution, 400mg and 800mg Epidiolex® to gather data on its effects on patients undergoing bilateral total knee arthroplasty (BTKA). We will be estimating whether Epidiolex® is associated with minimal opioid use and adequate analgesia. We will also assess its tolerability, pharmacokinetics, and effects on inflammatory markers in the perioperative setting.
Recruiting2 awards Phase 43 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Hospital for Special Surgery?
Hospital for Special Surgery is a medical facility located in New York, New York. This center is recognized for care of Osteoarthritis, Multiple Sclerosis, Arthritis, Systemic Scleroderma, Scleroderma and other specialties. Hospital for Special Surgery is involved with conducting 383 clinical trials across 382 conditions. There are 57 research doctors associated with this hospital, such as Dale J Lange, MD, Karen Onel, MD, Robert Spiera, MD, and Jose Rodriguez, MD.
Where is Hospital for Special Surgery located?
The Hospital for Special Surgery is located at 535 East 70th Street, Manhattan, New York.
Who should I call to ask about financial aid or insurance network?
**Hospital for Special Surgery Contact Information**
**Financial Assistance:**
- **Phone:** 212.606.1505
- **Address:** 535 East 70th Street, ERP Plaza Level, New York, NY 10021
**Insurance:**
- **Phone:** 212.606.1505
- **Address:** 535 East 70th Street, ERP Plaza Level, New York, NY 10021
For more information, visit [www.hss.edu](http://www.hss.edu) or email [info@hss.edu](mailto:info@hss.edu).
What insurance does Hospital for Special Surgery accept?
The Hospital for Special Surgery (HSS) accepts most major insurance plans for hospital services. However, it's important to verify with individual HSS physicians as coverage acceptance may vary. For detailed information on insurance plans accepted and assistance with "out-of-network" benefits, contact the HSS Insurance Advisory Service at 212.774.2607 or visit their website.
What awards or recognition has Hospital for Special Surgery received?
Hospital for Special Surgery (HSS) in New York, NY is renowned for its exceptional research and care, holding the No. 1 rank in orthopedics for 14 consecutive years by U.S. News & World Report (2023-2024). Additionally, HSS has earned its fourth consecutive Magnet® designation, representing the pinnacle of nursing excellence, awarded by the American Nurses Credentialing Center (ANCC).